Professor of Medicine, Thomas Jefferson University
Cardiology
Dr. Peter R. Kowey, MD
|
|
Give Review
Peter Kowey practices Cardiology. He researched medicine at Perelman School of Medicine at the University of Pennsylvania. He over the years received 3 awards: "Philadelphia Magazine", "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACC)". Doctor Peter R. Kowey, MD is a published physician as well. He has 98 publications published. The latest was: Sinus Node Dysfunction Is Associated With Higher Symptom Burden and Increased Comorbid Illness: Results From the ORBIT-AF Registry. Peter R. Kowey, MD is registered with Medicare.
Publications
- Sinus Node Dysfunction Is Associated With Higher Symptom Burden and Increased Comorbid Illness: Results From the ORBIT-AF Registry.
- Smoothing the Bumpy Road to Antiarrhythmic Drug Development.
- Cardiovascular Safety Outcome Trials: A meeting report from the Cardiac Safety Research Consortium.
- Effect of the 2014 Atrial Fibrillation Guideline Revisions on the Proportion of Patients Recommended for Oral Anticoagulation.
- Heart rate is associated with progression of Atrial fibrillation, independent of rhythm.
- Heterogeneous distribution of INa-L determines interregional differences in rate adaptation of repolarization.
- Are the novel anticoagulants better than warfarin for patients with Atrial fibrillation?
- Use and Outcomes Associated with Bridging During Anticoagulation Interruptions in Patients with Atrial Fibrillation: Findings from the Outcomes Registry for Better Inf...
- Antiarrhythmic Drug Therapy for Atrial Fibrillation.
- The impact of medical malpractice litigation on cardiovascular practice in the US and China.
- Does Atrial fibrillation pattern affect stroke risk? Data dredging to help the clinician.
- In memoriam tribute to dusan z. Kocovic, MD.
- Underrepresentation of Women, Elderly Patients, and Racial Minorities in the Randomized Trials Used for Cardiovascular Guidelines.
- Oral Anticoagulant Use Around the Time of Atrial Fibrillation Ablation: A Review of the Current Evidence of Individual Oral Anticoagulant Use for Periprocedural Atrial...
- Hypertrophic Cardiomyopathy: Can the noninvasive diagnostic testing identify high risk patients?
- Lack of Concordance Between Empirical Scores and Physician Assessments of Stroke and Bleeding Risk in Atrial Fibrillation: Results From the Outcomes Registry for Bette...
- The Role of Dronedarone in the Treatment of Atrial Fibrillation/Flutter in the Aftermath of PALLAS.
- The Electrocardiographic Manifestations of Arrhythmogenic Right Ventricular Dysplasia.
- Physician practices regarding contraindications to oral anticoagulation in Atrial fibrillation: Findings from the Outcomes Registry for Better Informed Treatment of At...
- Unanswered Questions in Patients With Concurrent Atrial Fibrillation and Acute Coronary Syndrome.
- Drug-induced long-QT Syndrome and torsade de pointes: an underrated problem?
- Electrical Failure of an ICD Lead due to a Presumed Insulation Defect Only Diagnosed by a Maximum Output Shock.
- Mega-epsilon waves on 12-lead ECG - just another case of arrhythmogenic right ventricular dysplasia/Cardiomyopathy?
- Oral Anticoagulants to Reduce the Risk of Stroke in Atrial Fibrillation: How Should a Clinician Choose?
- Rate versus rhythm control for management of Atrial fibrillation in clinical practice: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibri...
- Assessment of drug-induced increases in blood pressure during drug development: report from the Cardiac Safety Research Consortium.
- Predictors of Progression of Recently Diagnosed Atrial Fibrillation in REgistry on Cardiac Rhythm DisORDers Assessing the Control of Atrial Fibrillation (RecordAF)-Uni...
- Effects of dronedarone started rapidly after amiodarone discontinuation.
- Differentiating electrophysiological effects and cardiac safety of drugs based on the electrocardiogram: A blinded validation.
- The Food and Drug Administration Decision Not to Approve the 110 Mg Dose of Dabigatran: Give Us a Way Out.
- Stroke prevention in Atrial fibrillation.
- Celivarone for Maintenance of Sinus Rhythm and Conversion of Atrial Fibrillation/Flutter.
- What's a Mother to Do?
- Celivarone in patients with an implantable cardioverter-defibrillator (ICD): Adjunctive therapy for the reduction of ventricular arrhythmia-triggered ICD interventions.
- Outcomes registry for better informed treatment of Atrial fibrillation: Rationale and design of ORBIT-AF.
- Assessment of the pharmacokinetics and platelet aggregation inhibitory effects of a novel intravenous formulation of clopidogrel in humans.
- Thoroughly Measuring The QT Interval: Can We Find The Shortcuts?
- A piece of my mind. The silent majority.
- Contribution of late sodium current (I(Na-L)) to rate adaptation of ventricular repolarization and reverse use-dependence of QT-prolonging agents.
- How much has malpractice litigation altered the care of cardiac rhythm patients?
- Role of antiarrhythmic drugs: frequent implantable cardioverter-defibrillator shocks, risk of proarrhythmia, and new drug therapy.
- Atrial fibrillation: pharmacological therapy.
- Electrophysiological properties of HBI-3000: a new antiarrhythmic agent with multiple-channel blocking properties in human ventricular myocytes.
- Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic Atrial fibrillation: a randomized controlled trial.
- Why did you order that echocardiogram?
- Evaluation of toxicity for Heart failure therapeutics: studying effects on the QT interval.
- Increased late sodium current in left atrial myocytes of rabbits with left ventricular hypertrophy: its role in the genesis of atrial Arrhythmias.
- The RecordAF study: design, baseline data, and profile of patients according to chosen treatment strategy for Atrial fibrillation.
- Physician stated Atrial fibrillation management in light of treatment guidelines: data from an international, observational prospective survey.
- Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia ablation versus drugs for preventing ICD shocks: role of adjuvant ...
- Evaluation of the effects of PM101, a cyclodextrin-based formulation of intravenous amiodarone, on blood pressure in healthy humans.
- Comparison of the cardiac electrophysiology and general toxicology of two formulations of intravenous amiodarone in dogs.
- Dronedarone.
- Efficacy and safety of prescription omega-3-acid ethyl esters for the prevention of recurrent symptomatic Atrial fibrillation: a prospective study.
- Assessing proarrhythmic potential of drugs when optimal studies are infeasible.
- Bioequivalence of 2 intravenous amiodarone formulations in healthy participants.
- Is there a significant transmural gradient in repolarization time in the intact Heart? Cellular basis of the T wave: a century of controversy.
- Dronedarone: a new treatment for Atrial fibrillation.
- New horizons in antiarrhythmic therapy: will novel agents overcome current deficits?
- Calcium-activated chloride current contributes to action potential alternations in left ventricular hypertrophy rabbit.
- The geriatric paradox.
- L-type calcium current recovery versus ventricular repolarization: preserved membrane-stabilizing mechanism for different QT intervals across species.
- Drug therapy for Atrial fibrillation.
- Discarding the baby with the bathwater.
- Non-antiarrhythmic drugs in Atrial fibrillation: a review of non-antiarrhythmic agents in prevention of Atrial fibrillation.
- The diagnosis of cardiac Arrhythmias: a prospective multi-center randomized study comparing mobile cardiac outpatient telemetry versus standard loop event monitoring.
- L-type calcium current reactivation contributes to arrhythmogenesis associated with action potential triangulation.
- Sudden death secondary to cardiac Arrhythmias: mechanisms and treatment strategies.
- Antiarrhythmic drug therapy.
- Blinded validation of the isolated arterially perfused rabbit ventricular wedge in preclinical assessment of drug-induced proArrhythmias.
- Fast-track training of nonelectrophysiologists to implant defibrillators: is it needed?
- "Doctor, why didn't you tell me about this before the ICD?".
- Hospitalizations for new Heart failure among subjects with diabetes mellitus in the RENAAL and LIFE studies.
- Real-world algorithms for the optimal use of drugs and devices in the patient post Myocardial infarction and the future of post Myocardial infarction management.
- The QT and Tp-e intervals in left and right chest leads: comparison between patients with systemic and pulmonary Hypertension.
- ProArrhythmias and antiArrhythmias: two sides of the same coin.
- Selection of drugs in pursuit of a rhythm control strategy.
- Making a silk purse out of a sow's ear.
- Assessment of the proarrhythmic potential of the novel antiarrhythmic agent AZD7009 and dofetilide in experimental models of torsades de pointes.
- A review of carvedilol arrhythmia data in clinical trials.
- First experience with a Mobile Cardiac Outpatient Telemetry (MCOT) system for the diagnosis and management of cardiac arrhythmia.
- ECG repolarization waves: their genesis and clinical implications.
- Pharmacologic therapies for Atrial fibrillation.
- A pharmacokinetic study of the combined administration of amiodarone and ximelagatran, an oral direct thrombin inhibitor.
- The clinical use of angiotensin-converting enzyme inhibitors.
- Phase 2 reentry as a trigger to initiate ventricular fibrillation during early Acute myocardial ischemia.
- Case of polymorphic ventricular tachycardia in diphenhydramine poisoning.
- You only get so many Heartbeats...
- Overview of the management of Atrial fibrillation: what is the current state of the art?
- I've fallen and I can't get up.
- Ventricular repolarization components on the electrocardiogram: cellular basis and clinical significance.
- Cardiology patient pages. Ambulatory electrocardiographic recording.
- Pharmacologic and nonpharmacologic options to maintain sinus rhythm: guideline-based and new approaches.
- Electrophysiologic effects of SB-237376: a new antiarrhythmic compound with dual potassium and calcium channel blocking action.
- Effect of epicardial or biventricular pacing to prolong QT interval and increase transmural dispersion of repolarization: does resynchronization therapy pose a risk fo...
- Ischemia versus amiodarone induced polymorphic ventricular tachycardia.
- Increasing I(Ks) corrects abnormal repolarization in rabbit models of acquired LQT2 and ventricular hypertrophy.
Procedures Preformed
- Automatic Implantable Cardioverter Defibrillator (ICD) Implantation
- Cardiac Imaging
- Cardiac Myocardial Perfusion Imaging
- Cardioverter-Defibrillator or Pacemaker Insertion, Removal or Repair
- View All
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Valve Disease
- Arrhythmias (incl. Atrial Fibrillation)
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Personal Choice PPO
- Regional Pref Network EPO
- Regional Pref Network HMO
- Regional Pref Network HMO+
- Regional Pref Network POS+
- Regional Pref Network PPO
- Blue Card PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- CoreSource
- Coventry Health America PPO
- Coventry Health Care of Delaware PPO
- First Health (Coventry Health Care) PPO
- HealthPartners
- Community Blue PPO
- Choice Care PPO
- Keystone Health Plan East HMO
- Medicare MCR
- Medico
- MultiPlan PPO
- PHCS Network PPO
- Freedom Plan
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- Oxford Liberty
- United Healthcare
Awards
- Philadelphia Magazine
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACC)
Education
-
Brigham and Women's Hospital -
Penn State University -
Perelman School of Medicine at the University of Pennsylvania
Drug Facts
| NPI NUMBER | 1114922945 | |
| NPPES Provider LastName | KOWEY | |
| NPPES Provider FirstName | PETER | |
| NPPES Provider ZIPCode | 190963450 | |
| NPPES Provider State | PA | |
| Specialty Description | Cardiology | |
| Total Claim Count | 439.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1114922945 |
| Last Name Of The Provider | KOWEY |
| First Name Of The Provider | PETER |
| View All |
Similar Doctors
|
Dr. Ghazi A. Mirrani, MD |
|
|
Dr. Alvin G. Heller, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jared S. Videll, DO |
|
|
Dr. Marwan Badri, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Douglas B. Esberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert H. Schwab, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Avinash R. Khitri, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward Solow, MD |
|
Dr. Henry S. Sawin Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steve A. Vaganos, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Christopher J. Droogan, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Irving M. Herling, MD
This Doctor is OpenDoctor Recommended.
|